{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:29:54Z","timestamp":1767976194456,"version":"3.49.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T00:00:00Z","timestamp":1293667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12016-010-8238-7","type":"journal-article","created":{"date-parts":[[2010,12,29]],"date-time":"2010-12-29T04:05:25Z","timestamp":1293595525000},"page":"179-189","source":"Crossref","is-referenced-by-count":24,"title":["Cutting Edge Issues in Polymyositis"],"prefix":"10.1007","volume":"41","author":[{"given":"Anna","family":"Ghirardello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Tarricone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Gorza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,30]]},"reference":[{"key":"8238_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first part). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"8238_CR2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second part). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"8238_CR3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"8238_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00002826-199210000-00001","volume":"15","author":"MC Dalakas","year":"1992","unstructured":"Dalakas MC (1992) Clinical, immunopathologic and therapeutic considerations of inflammatory myopathies. Clin Neuropharmacol 15:327\u2013351","journal-title":"Clin Neuropharmacol"},{"key":"8238_CR5","doi-asserted-by":"crossref","first-page":"A330","DOI":"10.1016\/j.autrev.2009.11.006","volume":"9","author":"S Prieto","year":"2010","unstructured":"Prieto S, Grau JM (2010) The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 9:A330\u2013A334","journal-title":"Autoimmun Rev"},{"key":"8238_CR6","first-page":"782","volume":"28","author":"PR Mathiesen","year":"2010","unstructured":"Mathiesen PR, Zak M, Heilin T, Nielsen SM (2010) Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients. Clin Exp Rheumatol 28:782\u2013789","journal-title":"Clin Exp Rheumatol"},{"key":"8238_CR7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.55.12.1509","volume":"55","author":"MC Dalakas","year":"1998","unstructured":"Dalakas MC (1998) Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol 55:1509\u20131512","journal-title":"Arch Neurol"},{"key":"8238_CR8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/08916930903002511","volume":"42","author":"C Grundtman","year":"2009","unstructured":"Grundtman C, Lundberg IE (2009) Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies. Autoimmunity 42:615\u2013626","journal-title":"Autoimmunity"},{"key":"8238_CR9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/BOR.0b013e3282efe261","volume":"19","author":"SA Greenberg","year":"2007","unstructured":"Greenberg SA (2007) A gene expression approach to study perturbed pathways in myositis. Curr Opin Rheumatol 19:536\u2013541","journal-title":"Curr Opin Rheumatol"},{"key":"8238_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/08916930903510955","volume":"43","author":"IE Lundberg","year":"2010","unstructured":"Lundberg IE, Helmers SB (2010) The type I interferon system in idiopathic inflammatory myopathies. Autoimmunity 43:239\u2013243","journal-title":"Autoimmunity"},{"key":"8238_CR11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/08916930600622173","volume":"39","author":"G Chevrel","year":"2006","unstructured":"Chevrel G, Page G, Miossec P (2006) Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis. Autoimmunity 39:171\u2013176","journal-title":"Autoimmunity"},{"key":"8238_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08916930600622256","volume":"39","author":"S Salomonsson","year":"2006","unstructured":"Salomonsson S, Lundberg IE (2006) Cytokines in idiopathic inflammatory myopathies. Autoimmunity 39:177\u2013190","journal-title":"Autoimmunity"},{"key":"8238_CR13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen L, Nagaraij K, Plots P, Wang K, Levine S, Gabrielson E et al (2005) Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 201:591\u2013601","journal-title":"J Exp Med"},{"key":"8238_CR14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1525-1594.2005.29032.x","volume":"29","author":"U Carraro","year":"2005","unstructured":"Carraro U, Rossini K, Mayr W, Kern H (2005) Muscle fiber regeneration in human permanent lower motoneuron denervation: relevance to safety and effectiveness of FES-training, which induces muscle recovery in SCI subjects. Artif Organs 29:187\u2013191","journal-title":"Artif Organs"},{"key":"8238_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2005.08.021","volume":"122","author":"AJ Wagers","year":"2005","unstructured":"Wagers AJ, Concoy IM (2005) Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122:659\u2013667","journal-title":"Cell"},{"key":"8238_CR16","first-page":"485","volume":"6","author":"M Cantini","year":"1996","unstructured":"Cantini M, Carraro U (1996) Control of cell proliferation by macrophage-myoblast interactions. Basic Appl Myol 6:485\u2013490","journal-title":"Basic Appl Myol"},{"key":"8238_CR17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20070075","volume":"204","author":"L Arnold","year":"2007","unstructured":"Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Planquet A et al (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into anti-inflammatory macrophages to support myogenesis. JEM 204:1057\u20131069","journal-title":"JEM"},{"key":"8238_CR18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.tcb.2005.10.007","volume":"15","author":"J Dhawan","year":"2005","unstructured":"Dhawan J, Rando TA (2005) Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 15:666\u2013673","journal-title":"Trends Cell Biol"},{"key":"8238_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1179\/174313208X281154","volume":"30","author":"S Zampieri","year":"2008","unstructured":"Zampieri S, Biral D, Adami N, Ghirardello A, Rampudda M, Tonello M et al (2008) Expression of myositis specific autoantigens during postnatal myogenesis. Neurol Res 30:145\u2013148","journal-title":"Neurol Res"},{"key":"8238_CR20","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00454.2004","volume":"288","author":"JG Tidball","year":"2005","unstructured":"Tidball JG (2005) Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288:R345\u2013R353","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"8238_CR21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96\u2013100","journal-title":"Lancet"},{"key":"8238_CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"326","author":"B Sigurgeirsson","year":"1992","unstructured":"Sigurgeirsson B, Lindel\u00f6f B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326:363\u2013367","journal-title":"N Engl J Med"},{"key":"8238_CR23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","volume":"134","author":"R Buchbinder","year":"2001","unstructured":"Buchbinder R, Forbes A, Hall S, Dennett X, Giles G (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134:1087\u20131095","journal-title":"Ann Intern Med"},{"key":"8238_CR24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-4362.2002.01648.x","volume":"41","author":"N Wakata","year":"2002","unstructured":"Wakata N, Kurihara T, Saito E, Kinoshita M (2002) Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 41:729\u2013734","journal-title":"Int J Dermatol"},{"key":"8238_CR25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/ard.60.5.433","volume":"60","author":"M Abu-Shakra","year":"2001","unstructured":"Abu-Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y (2001) Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 60:433\u2013440","journal-title":"Ann Rheum Dis"},{"key":"8238_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002281-200301000-00007","volume":"15","author":"E Chakravarty","year":"2003","unstructured":"Chakravarty E, Genovese MC (2003) Rheumatic syndromes associated with malignancy. Curr Opin Rheumatol 15:35\u201343","journal-title":"Curr Opin Rheumatol"},{"key":"8238_CR27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.autrev.2008.02.001","volume":"7","author":"V Raccanelli","year":"2008","unstructured":"Raccanelli V, Prete M, Minoia C, Favoino E, Perosa F (2008) Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev 7:352\u2013358","journal-title":"Autoimmun Rev"},{"key":"8238_CR28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00296-005-0005-3","volume":"26","author":"C Andr\u00e1s","year":"2006","unstructured":"Andr\u00e1s C, Csiki Z, Ponyi A, Ill\u00e9s A, Dank\u00f3 K (2006) Paraneoplastic rheumatic syndromes. Rheumatol Int 26:376\u2013382","journal-title":"Rheumatol Int"},{"key":"8238_CR29","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867","journal-title":"Nature"},{"key":"8238_CR30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2006.04.002","volume":"6","author":"LC Eisenlohr","year":"2006","unstructured":"Eisenlohr LC, Rothstein JL (2006) Oncogenic inflammation and autoimmune disease. Autoimmun Rev 6:107\u2013114","journal-title":"Autoimmun Rev"},{"key":"8238_CR31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.bor.0000245721.02512.77","volume":"18","author":"SM Levine","year":"2006","unstructured":"Levine SM (2006) Cancer and myositis: new insights into an old association. Curr Opin Rheumatol 18:620\u2013624","journal-title":"Curr Opin Rheumatol"},{"key":"8238_CR32","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.4049\/jimmunol.172.7.4059","volume":"172","author":"JP Russel","year":"2004","unstructured":"Russel JP, Engiles JB, Rothstein JL (2004) Proinflammatory mediators and genetic background in oncogene mediated tumor progression. J Immunol 172:4059\u20134067","journal-title":"J Immunol"},{"key":"8238_CR33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1179\/016164110X12556180205997","volume":"32","author":"S Zampieri","year":"2010","unstructured":"Zampieri S, Doria A, Adami N, Biral N, Vecchiato M, Savastano S et al (2010) Subclinical myopathy in patients affected with early stage colorectal cancer at disease onset: evidence from skeletal muscle biopsies. Neurol Res 32:20\u201325","journal-title":"Neurol Res"},{"key":"8238_CR34","first-page":"247","volume":"19","author":"S Zampieri","year":"2009","unstructured":"Zampieri S, Valente M, Adami N, Corbianco S, Doria A, Biral D et al (2009) Subclinical myopathy in patients affected with early stage colorectal cancer at disease onset: no evidence of inflammatory cells infiltration in the skeletal muscle biopsies harvested during diagnostic laparoscopy. Basic Appl Myol 19:247\u2013252","journal-title":"Basic Appl Myol"},{"key":"8238_CR35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","volume":"9","author":"S Zampieri","year":"2010","unstructured":"Zampieri S, Valente M, Adami N, Biral N, Ghirardello A, Rampudda M et al (2010) Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev 9:449\u2013453","journal-title":"Autoimmun Rev"},{"key":"8238_CR36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70:360\u2013374","journal-title":"Medicine"},{"key":"8238_CR37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer R, Hengstmam GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A et al (2001) Autoantibodies profiles in the sera of European patients with myositis. Ann Rheum Dis 60:116\u2013123","journal-title":"Ann Rheum Dis"},{"key":"8238_CR38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","volume":"39","author":"A Ghirardello","year":"2006","unstructured":"Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C et al (2006) Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 39:217\u2013221","journal-title":"Autoimmunity"},{"key":"8238_CR39","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","volume":"66","author":"H Chinoy","year":"2007","unstructured":"Chinoy H, Fertig N, Oddis CV, Ollier WER, Cooper RG (2007) The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 66:1345\u20131349","journal-title":"Ann Rheum Dis"},{"key":"8238_CR40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Gauler JR, Raymand Y, Senecal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap features and autoantibodies. Medicine 84:231\u2013249","journal-title":"Medicine"},{"key":"8238_CR41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jbspin.2006.04.005","volume":"73","author":"C Sordet","year":"2006","unstructured":"Sordet C, Goetz J, Sibilia J (2006) Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. J Bone Spine 73:646\u2013654","journal-title":"J Bone Spine"},{"key":"8238_CR42","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","volume":"9","author":"M Koenig","year":"2007","unstructured":"Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senecal JL (2007) Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 9:R78","journal-title":"Arthritis Res Ther"},{"key":"8238_CR43","first-page":"1393","volume":"29","author":"F Franceschini","year":"2002","unstructured":"Franceschini F, Cavazzana I, Generali D, Quinzanini M, Ghirardello A, Doria A et al (2002) Anti-Ku Antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol 29:1393\u20131397","journal-title":"J Rheumatol"},{"key":"8238_CR44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","volume":"109","author":"SA Rutjes","year":"1997","unstructured":"Rutjes SA, Vree Egberts WTM, Jongen P, van den Hoogen F, Prujin GJM, van Venrooij WJ (1997) Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 109:32\u201340","journal-title":"Clin Exp Immunol"},{"key":"8238_CR45","unstructured":"Defendenti C, Atzeni F, Spina MF, Grosso S, Cereda A, Guercilena G et al (2010) Clinical and laboratory aspects of Ro\/SSA-52 autoantibodies. Autoimmun Rev, Sep 18 (Epub ahead of print) PMID: 20854935"},{"key":"8238_CR46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","volume":"77","author":"A V\u00e1ncsa","year":"2010","unstructured":"V\u00e1ncsa A, Gergely L, Ponyi A, Lakos G, Nemeth J, Szodoray P et al (2010) Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis. Relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine 77:125\u2013130","journal-title":"Joint Bone Spine"},{"key":"8238_CR47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/08916930400022640","volume":"38","author":"S Zampieri","year":"2005","unstructured":"Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A (2005) Anti-Jo-1 antibodies. Autoimmunity 38:73\u201378","journal-title":"Autoimmunity"},{"key":"8238_CR48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/08916930400022681","volume":"38","author":"A Ghirardello","year":"2005","unstructured":"Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF et al (2005) Anti-Mi-2 autoantibodies. Autoimmunity 38:79\u201383","journal-title":"Autoimmunity"},{"key":"8238_CR49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2005.040717","volume":"65","author":"GJD Hengstman","year":"2006","unstructured":"Hengstman GJD, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J et al (2006) Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2\u03b2 antigen. Ann Rheum Dis 65:242\u2013245","journal-title":"Ann Rheum Dis"},{"key":"8238_CR50","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","volume":"65","author":"GJ Hengstman","year":"2006","unstructured":"Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J et al (2006) Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65:1635\u20131638","journal-title":"Ann Rheum Dis"},{"key":"8238_CR51","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52:1571\u20131576","journal-title":"Arthritis Rheum"},{"key":"8238_CR52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura T et al (2007) Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology 46:25\u201328","journal-title":"Rheumatology"},{"key":"8238_CR53","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/art.22862","volume":"56","author":"Z Betteridge","year":"2007","unstructured":"Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N (2007) Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum 56:3132\u20133137","journal-title":"Arthritis Rheum"},{"key":"8238_CR54","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL (2010) A novel autoantibody recognizing 200-kd and 100-kd proteins is Associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 62:2757\u20132766","journal-title":"Arthritis Rheum"},{"key":"8238_CR55","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/BOR.0b013e328331638a","volume":"21","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, McHugh NJ (2009) Pathogenic mechanisms of disease in myositis: autoantigens as clues. Curr Opin Rheumatol 21:604\u2013609","journal-title":"Curr Opin Rheumatol"},{"key":"8238_CR56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/BOR.0b013e328313bff4","volume":"20","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, Betteridge ZE, McHugh NJ (2008) Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol 20:675\u2013680","journal-title":"Curr Opin Rheumatol"},{"key":"8238_CR57","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.1002\/art.20784","volume":"52","author":"L Hashish","year":"2005","unstructured":"Hashish L, Trieu EP, Sadanandan P, Targoff IN (2005) Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome (abstract). Arthritis Rheum 52:S312","journal-title":"Arthritis Rheum"},{"key":"8238_CR58","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kem045","volume":"46","author":"Z Betteridge","year":"2007","unstructured":"Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N (2007) Antisynthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology 46:1005\u20131008","journal-title":"Rheumatology"},{"key":"8238_CR59","first-page":"1565","volume":"83","author":"WJ Zheng","year":"2003","unstructured":"Zheng WJ, Wei W, Tang FL (2003) Clinical features and misdiagnosis of anti-Jo-1 syndrome: analysis of 33 cases. Zhongua Yi Xue Zhi 83:1565\u20131568","journal-title":"Zhongua Yi Xue Zhi"},{"key":"8238_CR60","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.21883","volume":"54","author":"Y Yamasaki","year":"2006","unstructured":"Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R et al (2006) Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis. Arthritis Rheum 54:2004\u20132009","journal-title":"Arthritis Rheum"},{"key":"8238_CR61","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","volume":"28","author":"IN Targoff","year":"1985","unstructured":"Targoff IN, Reichlin M (1985) The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28:796\u2013803","journal-title":"Arthritis Rheum"},{"key":"8238_CR62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/art.1780380119","volume":"38","author":"DS Nilasena","year":"1995","unstructured":"Nilasena DS, Trieu EP, Targoff IN (1995) Analysis of the Mi-2 autoantigen of dermatomyositis. Arthritis Rheum 38:123\u2013128","journal-title":"Arthritis Rheum"},{"key":"8238_CR63","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/nar\/29.12.2517","volume":"15","author":"HB Wang","year":"2001","unstructured":"Wang HB, Zhang Y (2001) Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor. Nucleic Acid Res 15:2517\u20132521","journal-title":"Nucleic Acid Res"},{"key":"8238_CR64","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/art.1780390521","volume":"39","author":"R Mierau","year":"1996","unstructured":"Mierau R, Dick T, Bartz-Bazzanella P, Keller E, Albert ED, Genth E (1996) Strong association of dermatomyositis specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR\u03b2 chain. Arthritis Rheum 39:868\u20137636","journal-title":"Arthritis Rheum"},{"key":"8238_CR65","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/299691a0","volume":"299","author":"P Walter","year":"1982","unstructured":"Walter P, Blobel G (1982) Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum. Nature 299:691\u2013698","journal-title":"Nature"},{"key":"8238_CR66","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar1895","volume":"8","author":"K Romisch","year":"2006","unstructured":"Romisch K, Miller FW, Dobberstein B, High S (2006) Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages. Arthritis Res Ther 8:R39","journal-title":"Arthritis Res Ther"},{"key":"8238_CR67","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","volume":"83","author":"WH Reeves","year":"1986","unstructured":"Reeves WH, Ngam SK, Blobel G (1986) Humna autoantibodies reactive with the signal recognition particle. Proc Natl Acad Sci USA 83:9507\u20139511","journal-title":"Proc Natl Acad Sci USA"},{"key":"8238_CR68","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/rheumatology\/kep027","volume":"48","author":"BR Whelan","year":"2009","unstructured":"Whelan BR, Isenberg DA (2009) Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion. Rheumatology 48:594\u2013595","journal-title":"Rheumatology"},{"key":"8238_CR69","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","volume":"73","author":"T Miller","year":"2002","unstructured":"Miller T, Al-Lozi MT, Pestronk A (2002) Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 73:420\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8238_CR70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","volume":"50","author":"AH Kao","year":"2004","unstructured":"Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV (2004) Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 50:209\u2013215","journal-title":"Arthritis Rheum"},{"key":"8238_CR71","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/ken325","volume":"47","author":"S Suzuki","year":"2008","unstructured":"Suzuki S, Satoh T, Sato S, Otomo M, Hirayama Y, Sato H et al (2008) Clinical utility od anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology 47:1539\u20131542","journal-title":"Rheumatology"},{"key":"8238_CR72","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O\u2019Hanlon TP et al (2006) A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 54:3682\u20133689","journal-title":"Arthritis Rheum"},{"key":"8238_CR73","doi-asserted-by":"crossref","first-page":"S518","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff IN, Trieu EP, Levy-Neto M, Prasertsuntarsai T (2006) Autoantibodies to transcriptional intermediary factor 1-gamma (TIF1-g) in dermatomyositis (abstract). Arthritis Rheum 54:S518","journal-title":"Arthritis Rheum"},{"key":"8238_CR74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","volume":"89","author":"E Trallero-Araguas","year":"2010","unstructured":"Trallero-Araguas E, Labrador-Horrillo M, Selva-O\u2019Callaghan A, Martinez MA, Martinez-Gomez X, Palou E et al (2010) Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine 89:47\u201352","journal-title":"Medicine"},{"key":"8238_CR75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/kep298","volume":"49","author":"K Hoshino","year":"2010","unstructured":"Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T (2010) Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology 49:3\u20131726","journal-title":"Rheumatology"},{"key":"8238_CR76","doi-asserted-by":"crossref","first-page":"S923","DOI":"10.1002\/art.23805","volume":"58","author":"S Sato","year":"2008","unstructured":"Sato S, Hoshino K, Satoh T, Suwa A, Hirakata M (2008) MDA5 (melanoma differentiation-associated gen 5) as an autoantigen recognized by anti-CADM-140 antibody in patients with clinically amyopathic dermatomyositis (abstract). Arthritis Rheum 58:S923","journal-title":"Arthritis Rheum"},{"key":"8238_CR77","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","volume":"68","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG et al (2009) Clinical and HLA-class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK adult-onset Caucasian myositis. Ann Rheum Dis 68:1621\u20131625","journal-title":"Ann Rheum Dis"},{"key":"8238_CR78","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.autrev.2009.02.012","volume":"8","author":"A Ghirardello","year":"2009","unstructured":"Ghirardello A, Bendo R, Rampudda ME, Bassi N, Zampieri S, Doria A (2009) Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev 8:645\u2013649","journal-title":"Autoimmun Rev"},{"issue":"12","key":"8238_CR79","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","volume":"49","author":"A Ghirardello","year":"2010","unstructured":"Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S et al (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology 49(12):2370\u20132374","journal-title":"Rheumatology"},{"key":"8238_CR80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.autrev.2009.03.005","volume":"9","author":"J Ronnelid","year":"2009","unstructured":"Ronnelid J, Barbasso Helmers S, Storfors H, Grip K, Ronnblom L, Frank-Larsson K et al (2009) Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 9:58\u201361","journal-title":"Autoimmun Rev"},{"key":"8238_CR81","volume-title":"Methods in molecular biology, protein blotting and detection, vol 536","author":"EP Trieu","year":"2009","unstructured":"Trieu EP, Gross JK, Targoff IN (2009) Immunoprecipitation-Western blot for proteins of low abundance, Chapter 28. In: Kurien BT, Scofield RH (eds) Methods in molecular biology, protein blotting and detection, vol 536. Humana, New York"},{"key":"8238_CR82","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/BOR.0b013e3283319265","volume":"21","author":"A Henriques-Pons","year":"2009","unstructured":"Henriques-Pons A, Nagaraju K (2009) Non-immune mechanisms of muscle damage in myositis: role of the reticulum stress response and autophagy in the disease pathogenesis. Curr Opin Rheumatol 21:581\u2013587","journal-title":"Curr Opin Rheumatol"},{"key":"8238_CR83","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI0216886","volume":"110","author":"RJ Kaufman","year":"2002","unstructured":"Kaufman RJ (2002) Orchestrating the unfolded protein response in health and disease. J Clin Invest 110:1389\u20131398","journal-title":"J Clin Invest"},{"key":"8238_CR84","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI0216784","volume":"110","author":"D Ron","year":"2002","unstructured":"Ron D (2002) Translational control in the endoplasmic reticulum stress response. J Clin Invest 110:1383\u20131388","journal-title":"J Clin Invest"},{"key":"8238_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)63089-1","volume":"164","author":"G Vattemi","year":"2004","unstructured":"Vattemi G, King Engel W, McFerrin J, Askanas V (2004) Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 164:1\u20137","journal-title":"Am J Pathol"},{"key":"8238_CR86","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00401-009-0511-6","volume":"117","author":"G Vattemi","year":"2009","unstructured":"Vattemi G, Nogalska A, King Engel W, D\u2019Agostino C, Checler F, Askanas V (2009) Amyloid-b42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. Acta Neuropathol 117:569\u2013574","journal-title":"Acta Neuropathol"},{"key":"8238_CR87","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1212\/01.WNL.0000138574.56908.5D","volume":"63","author":"P Fratta","year":"2004","unstructured":"Fratta P, Engel WK, Van Leeuwen FV, Hol EM, Vattemi G, Askanas V (2004) Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers. Neurology 63:1114\u20131117","journal-title":"Neurology"},{"key":"8238_CR88","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R et al (2005) Activation of the endoplasmic reticulum response in autoimmune myositis. Arthritis Rheum 52:824\u2013835","journal-title":"Arthritis Rheum"},{"key":"8238_CR89","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/01.bor.0000179947.58271.9a","volume":"17","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K (2005) Role of major histocompatibility complex class I molecules in autoimmune myositis. Curr Opin Rheumatol 17:725\u2013730","journal-title":"Curr Opin Rheumatol"},{"key":"8238_CR90","first-page":"519","volume":"27","author":"AM Sallum","year":"2009","unstructured":"Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Sachetti S, Lotufo S et al (2009) MHC class I and II expression in juvenile dermatomyositis skeletal muscle. Clin Exp Rheumatol 27:519\u2013526","journal-title":"Clin Exp Rheumatol"},{"key":"8238_CR91","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.autrev.2009.02.026","volume":"8","author":"KK Creus","year":"2009","unstructured":"Creus KK, De Poepe B, De Bleecker JL (2009) Idiopathic inflammatory myopathies and the classical NK-kappaB complex: current insights and implications for therapy. Autoimmun Rev 8:627\u2013631","journal-title":"Autoimmun Rev"},{"key":"8238_CR92","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar2963","volume":"12","author":"M Vitadello","year":"2010","unstructured":"Vitadello M, Doria A, Tarricone E, Ghirardello A, Gorza L (2010) Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and sistemic inflammation. Arthritis Res Ther 12:R52","journal-title":"Arthritis Res Ther"},{"key":"8238_CR93","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1083\/jcb.200412024","volume":"169","author":"K Nakanishi","year":"2005","unstructured":"Nakanishi K, Sudo T, Morishima N (2005) Endoplasmic reticulum stress signalling transmitted by ATF6 mediates apoptosis during muscle development. J Cell Biol 169:555\u2013560","journal-title":"J Cell Biol"},{"key":"8238_CR94","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1196\/annals.1351.046","volume":"1069","author":"E Tarricone","year":"2006","unstructured":"Tarricone E, Ghirardello A, Zampieri A, Rampudda ME, Doria A, Gorza L (2006) Cell stress-response in skeletal muscle myofibers. Ann NY Acad Sci 1069:472\u2013476","journal-title":"Ann NY Acad Sci"},{"key":"8238_CR95","doi-asserted-by":"crossref","first-page":"15824","DOI":"10.1073\/pnas.2635458100","volume":"100","author":"B Liu","year":"2003","unstructured":"Liu B, Dai J, Zheng H, Stoilova D, Sun S, Li Z (2003) Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. PNAS 100:15824\u201315829","journal-title":"PNAS"},{"key":"8238_CR96","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1096\/fasebj.14.3.461","volume":"14","author":"L Gorza","year":"2000","unstructured":"Gorza L, Vitadello M (2000) Reduced amount of the glucose-regulated protein GRP94 in skeletal myoblasts results in loss of fusion competence. FASEB J 14:461\u2013475","journal-title":"FASEB J"},{"key":"8238_CR97","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1152\/japplphysiol.00280.2009","volume":"107","author":"L Dalla Libera","year":"2009","unstructured":"Dalla Libera L, Ravara B, Gobbo V, Tarricone E, Vitadello M, Gorza L (2009) A transient antioxidant stress response accompanies the onset of disuse atrophy in human skeletal muscle. J Appl Physiol 107:549\u2013557","journal-title":"J Appl Physiol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8238-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-010-8238-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8238-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T10:36:04Z","timestamp":1559903764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-010-8238-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,30]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["8238"],"URL":"https:\/\/doi.org\/10.1007\/s12016-010-8238-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,30]]}}}